Bioscience

ImmuneRegen BioSciences to present Homspera findings at BIO 2009

March 26, 2009

By Flinn Foundation

[Source: EarthTimes] – ImmuneRegen® BioSciences, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), will present its current findings on Homspera®, the company’s immune system-enhancing preclinical drug candidate, at the 2009 BIO International Convention (BIO 2009) May 18-21 in Atlanta, Ga.

For more information click here.